SMN2 and proximal spinal muscular atrophy: In conclusion, the results presented in this study show that the mean percentage of FL-SMN transcripts detected by semiquantitative and quantitative fluorescence RT-PCR can be used as a putative biomarker for the assessment of SMA therapy efficacy and for the development of new SMA drugs.